SPECIAL CHARGE	9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
SPECIAL CHARGE	SPECIAL CHARGE In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.

The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=114868817

Name:	us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration